Sleep Disorders Center of Alabama

Birmingham, Alabama 35213-1966

2 studies enrolling now · 29 studies all time

What they study most

Attention Deficit Hyperactivity Disorder, Cataplexy, Cataplexy Narcolepsy, Excessive Daytime Sleepiness, Excessive Daytime Somnolence, Healthy, Idiopathic Hypersomnia, Insomnia, Insufficient Sleep Syndrome, Narcolepsy, Narcolepsy Type 1, Narcolepsy Type 2

Studies at this site

• A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) — Recruiting now
• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• Study of SDX in Patients With Idiopathic Hypersomnia (IH) — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• An Open Label Study of FT218 in Subjects With Narcolepsy — Completed
• A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy — Completed
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy — Completed
• An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy — Completed
• DreamKit Diagnostic Validation — Completed
• eXciteOSA for Treatment of Mild Obstructive Sleep Apnea — Status unconfirmed
• eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea — Completed
• Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy — Completed
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy — Completed
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
• A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy — Completed
• A Study of the Effectiveness and Efficacy of the PowerSleep Device — Completed
• A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia — Status unconfirmed
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE
• Positive Pressure Treatment of Obstructive Sleep Apnea — Completed
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" — Completed
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" — Completed
• A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 — Completed
• VISC-Q Trial (Validation of an Online Sleep Characterization Questionnaire) — Completed
• The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea — Completed
• Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome — Completed
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed